Curzerene is a furanosesquiterpene strongly associated with myrrh and some Curcuma species, where it can be a major analytical marker. The source-backed evidence is strongest for identity and natural occurrence, with a smaller but real preclinical literature that includes influenza-virus experiments on isolated curzerene and additional mixture-level antimicrobial or larvicidal reports. Human evidence remains limited, so AromaForge should frame curzerene as a chemistry-rich constituent with early pharmacology signals rather than a proven wellness active.
Chemical identity and composition
PubChem returns Curzerene as CID 165365640 with formula C15H22O and CAS 17910-09-7. In the archive's myrrh records, curzerene sits within a furanosesquiterpene-heavy composition pattern. Literature summaries on Curcuma species also report curzerene as a recurring zedoary-type volatile, which helps explain why it appears across both resin and rhizome aromatic matrices.
Aroma and practical use
- Use the recorded resinous, balsamic, woody, spicy, resin descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
myrrh and curcuma marker constituent
A PubMed abstract on Commiphora myrrha extraction reported curzerene at 8.5% in the supercritical extract, alongside furanoeudesma-1,3-diene, lindestrene, and germacrone, and noted that hydrodistilled and steam-distilled oils were broadly similar.
Measured: major-component composition profiling
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
antiviral preclinical research
A PubMed abstract reported that curzerene and furanodienone both affected influenza A viral replication, with the paper stating that the two compounds acted on different steps of the virus life cycle.
Measured: viral replication interference
This experimental finding does not establish benefit, dose or safety in people using this blend.
mixture level antimicrobial or vector control context
A PubMed abstract on Brazilian Amazon essential oils reported promising larvicidal activity against Aedes aegypti in oils where curzerene was a major constituent in both seasons for one tested plant, but also reported high toxicity to non-target organisms and the need for additional safety studies.
Measured: larvicidal LC50 range and non-target toxicity
This experimental finding does not establish benefit, dose or safety in people using this blend.
myrrh and curcuma marker constituent
A Curcuma review abstract reported that Curcuma zedoaria rhizome oil can contain curzerene among its major volatiles, supporting its status as a recurring constituent outside myrrh.
Measured: presence in Curcuma zedoaria chemotypes
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No authoritative constituent-specific dermal limit or human safety trial for isolated curzerene was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The larvicidal paper located for curzerene-rich oils also reported high toxicity to non-target organisms, which is relevant as a cautionary ecological signal rather than a human-use limit.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Most antimicrobial or anti-inflammatory claims in accessible sources are mixture-level myrrh-oil findings and should not be rewritten as proven isolated-curzerene effects.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
LindestreneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Lindestrene report →How the effects were investigated
viral life cycle interference reported in influenza model
A myrrh-oil antiviral paper reported that curzerene affected influenza A viral replication and acted at a different life-cycle step than furanodienone.
This experimental finding does not establish benefit, dose or safety in people using this blend.
larvicidal context in curzerene rich oils
Curzerene-rich Amazonian essential oils showed promising Aedes aegypti larvicidal activity, though the same study also reported toxicity to non-target organisms and did not isolate curzerene alone as the sole active driver.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (8)
- No human clinical studies specific to isolated curzerene were verified in the reviewed sources.
- The strongest direct pharmacology evidence located here is still preclinical and relatively narrow.
- Accessible public safety literature remains too thin to justify a numeric topical-use ceiling for isolated curzerene.
- Follow-up web search (2026-07-11) targeting RIFM/IFRA myrrh/curzerene dermal-limit data again found no curzerene-specific RIFM safety assessment or IFRA Standard. dermal_limit_pct (20) and dermal_limit_verified (false) are left unchanged as an unverified placeholder.
- Re-check web search (2026-07-13) for curzerene dermal limit, sensitization, and phototoxicity again returned only generic RIFM/IFRA framework and myrrh-phototoxicity blog pages, with no curzerene-specific entry (myrrh itself is not on standard phototoxic-oil lists). The prior placeholder dermal_limit_pct (20%) had no locatable citation and was corrected to null rather than left as an unsupported number. sensitizing remains null (no data either way, not guessed).
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.